Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Priestman

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Scientific Reports|July 14, 2017
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral SclerosisAlexandre Henriques, Mylene Huebecker, Hélène Blasco, et al.
Analytical Biochemistry|July 22, 2004
Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labelingDavid C A Neville, Virginie Coquard, David A Priestman, et al.
Iscience|September 1, 2021
A modified density gradient proteomic-based method to analyze endolysosomal proteins in cardiac tissueThamali Ayagama, Samuel J Bose, Rebecca A Capel, et al.
International Journal of Molecular Sciences|March 11, 2023
A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and GlycosphingolipidsAnyelo Durán, David A Priestman, Macarena Las Heras, et al.
Biochemistry and Biophysics Reports|August 30, 2021
Identification of genetic modifiers of murine hepatic β-glucocerebrosidase activityAnyelo Durán, Boris Rebolledo-Jaramillo, Valeria Olguin, et al.
Journal of Medicinal Chemistry|November 8, 2017
N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe DiseaseDaniele D'Alonzo, Maria De Fenza, Caterina Porto, et al.
Acta Neuropathologica Communications|August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityOeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
Plos Biology|July 3, 2025
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunctionAlex S Nicholson, David A Priestman, Robin Antrobus, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammalsAnneliese O Speak, Mariolina Salio, David C A Neville, et al.
The Journal of Experimental Medicine|June 15, 2022
Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNATXuefang Pan, Mahsa Taherzadeh, Poulomee Bose, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Scientific Reports|July 14, 2017
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral SclerosisAlexandre Henriques, Mylene Huebecker, Hélène Blasco, et al.
Analytical Biochemistry|July 22, 2004
Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labelingDavid C A Neville, Virginie Coquard, David A Priestman, et al.
Iscience|September 1, 2021
A modified density gradient proteomic-based method to analyze endolysosomal proteins in cardiac tissueThamali Ayagama, Samuel J Bose, Rebecca A Capel, et al.
International Journal of Molecular Sciences|March 11, 2023
A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and GlycosphingolipidsAnyelo Durán, David A Priestman, Macarena Las Heras, et al.
Biochemistry and Biophysics Reports|August 30, 2021
Identification of genetic modifiers of murine hepatic β-glucocerebrosidase activityAnyelo Durán, Boris Rebolledo-Jaramillo, Valeria Olguin, et al.
Journal of Medicinal Chemistry|November 8, 2017
N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe DiseaseDaniele D'Alonzo, Maria De Fenza, Caterina Porto, et al.
Acta Neuropathologica Communications|August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityOeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
Plos Biology|July 3, 2025
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunctionAlex S Nicholson, David A Priestman, Robin Antrobus, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammalsAnneliese O Speak, Mariolina Salio, David C A Neville, et al.
The Journal of Experimental Medicine|June 15, 2022
Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNATXuefang Pan, Mahsa Taherzadeh, Poulomee Bose, et al.
Pageof 4